<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36855180</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1751-0759</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>BioPsychoSocial medicine</Title><ISOAbbreviation>Biopsychosoc Med</ISOAbbreviation></Journal><ArticleTitle>A patient who recovered from post-COVID myalgic encephalomyelitis/chronic fatigue syndrome: a case report.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13030-022-00260-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Some patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complain of persistent fatigue, dyspnea, pain, and cognitive dysfunction. These symptoms are often described as "long COVID". Whether a patient with long COVID might develop myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is of interest, as is the treatment and management of ME/CFS in a post-COVID patient. Here I report a patient, who, after an infection with SARS-CoV-2, developed ME/CFS and recovered after treatment.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">The patient was a previously healthy 55-year-old woman who worked as a nurse and became ill with COVID-19 pneumonia. She then presented with severe fatigue, post-exertional malaise, dyspnea, pain, cognitive dysfunction, tachycardia, and exacerbation of fatigue on physical exertion, which persisted for more than 6&#xa0;months after her recovery from COVID-19 pneumonia. She was bedridden for more than half of each day. The patient was treated from multiple perspectives, which included (1) instructions on eating habits and supplements; (2) cognitive and behavioral modifications for coping with physical, emotional, and cognitive fatigue; (3) instructions on conditioning exercises to improve deconditioning due to fatigue and dyspnea; and (4) pharmacotherapy with amitriptyline and hochuekkito, a Japanese herbal (Kampo) medicine. The patient made a complete recovery after completing the prescribed regimen and was able to return to work as a nurse.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To the best of my knowledge, this is the first detailed report on a patient infected with SARS-CoV-2 followed by long COVID with the signs/symptoms of ME/CFS who recovered after treatment. I hope this case report will be helpful to health care practitioners by its presentation of some of the therapeutic options for alleviating disabling signs/symptoms in patients with post-COVID ME/CFS.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oka</LastName><ForeName>Takakazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita, Chiba, 286-8520, Japan. okatakakazu@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biopsychosoc Med</MedlineTA><NlmUniqueID>101286572</NlmUniqueID><ISSNLinking>1751-0759</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">Post-COVID ME/CFS</Keyword><Keyword MajorTopicYN="N">Post-viral fatigue syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The author declares that he has no competing interests in relation to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36855180</ArticleId><ArticleId IdType="pmc">PMC9971667</ArticleId><ArticleId IdType="doi">10.1186/s13030-022-00260-3</ArticleId><ArticleId IdType="pii">10.1186/s13030-022-00260-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carfi A, Bernabei R, Landi F. Gemelli Against C-P-ACSG: persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study international chronic fatigue syndrome study group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles P, Sherkey JA, van de Sande MI. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Chron Fatigue Synd. 2003;11(1):7-115. 10.1300/J092v11n01_02.</Citation></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, So WY, Fong SY, Lam SP. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI. Myalgic encephalomyelitis/chronic fatigue syndrome: a clinical case definition and guidelines for medical practitioners - An Overview of the Canadian Consensus Document 2005. (ISBN: 0-9739335-0-X). http://www.investinme.org/Documents/PDFdocuments/Canadian_ME_Overview_A4.pdf. Accessed 10 July 2022.</Citation></Reference><Reference><Citation>Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003;25(2):106&#x2013;117. doi: 10.1016/S0885-3924(02)00596-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0885-3924(02)00596-1</ArticleId><ArticleId IdType="pubmed">12590026</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett JA, Labovitz SS. Effect of physical layout in performance of the Trail Making Test. Psychol Assess. 1995;7(2):220&#x2013;221. doi: 10.1037/1040-3590.7.2.220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/1040-3590.7.2.220</ArticleId></ArticleIdList></Reference><Reference><Citation>Japan Society for Higher Brain Dysfunction. BFTC: TMT-J. Tokyo (Japan): Shinkoh-Igaku Shuppansha; 2019.</Citation></Reference><Reference><Citation>Oka T, Kanemitsu Y, Sudo N, Hayashi H, Oka K. Psychological stress contributed to the development of low-grade fever in a patient with chronic fatigue syndrome: a case report. Biopsychosoc Med. 2013;7(1):7. doi: 10.1186/1751-0759-7-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1751-0759-7-7</ArticleId><ArticleId IdType="pmc">PMC3599992</ArticleId><ArticleId IdType="pubmed">23497734</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T. Efficacy and limitations of autogenic training as a treatment of chronic fatigue syndrome. Jpn J Autogenic Ther. 2015;35(1):12&#x2013;19.</Citation></Reference><Reference><Citation>Oka T. Usefulness of a &#x201c;fever-fatigue diary&#x201d; and &#x201c;energy savings passbook&#x201d; in treating patients with ME/CFS. J Fatigue Sci. 2019;14(2):16&#x2013;22.</Citation></Reference><Reference><Citation>Vollbracht C, Kraft K. Feasibility of vitamin C in the treatment of post viral fatigue with focus on long COVID, based on a systematic review of IV vitamin C on fatigue. Nutrients. 2021;13(4):1154. doi: 10.3390/nu13041154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13041154</ArticleId><ArticleId IdType="pmc">PMC8066596</ArticleId><ArticleId IdType="pubmed">33807280</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S, Nojima J, Motoki Y, Yamaguti K, Nakatomi Y, Okawa N, Fujiwara K, Watanabe Y, Kuratsune H. A potential biomarker for fatigue: oxidative stress and anti-oxidative activity. Biol Psychol. 2016;118:88&#x2013;93. doi: 10.1016/j.biopsycho.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsycho.2016.05.005</ArticleId><ArticleId IdType="pubmed">27224647</ArticleId></ArticleIdList></Reference><Reference><Citation>Varesi A, Deumer US, Ananth S, Ricevuti G. The emerging role of gut microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): current evidence and potential therapeutic applications. J Clin Med. 2021;10(21):5077. doi: 10.3390/jcm10215077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215077</ArticleId><ArticleId IdType="pmc">PMC8584653</ArticleId><ArticleId IdType="pubmed">34768601</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T. Shitsu-taikan-sho (alexisomia): a historical review and its clinical importance. Biopsychosoc Med. 2020;14:23. doi: 10.1186/s13030-020-00193-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13030-020-00193-9</ArticleId><ArticleId IdType="pmc">PMC7520027</ArticleId><ArticleId IdType="pubmed">32999684</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358(13):1327&#x2013;1335. doi: 10.1056/NEJMoa070447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa070447</ArticleId><ArticleId IdType="pubmed">18367735</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond) 2021;21(1):e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Shoenfeld Y. Post-COVID syndrome: the aftershock of SARS-CoV-2. Int J Infect Dis. 2022;114:233&#x2013;235. doi: 10.1016/j.ijid.2021.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.020</ArticleId><ArticleId IdType="pmc">PMC8590600</ArticleId><ArticleId IdType="pubmed">34785367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi H, Ishii M, Takeuchi S, Tanaka Y, Shintani T, Yamatodani A, Kusunoki T, Furue M. Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study. Evid Based Complement Alternat Med. 2010;7(3):367&#x2013;373. doi: 10.1093/ecam/nen003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecam/nen003</ArticleId><ArticleId IdType="pmc">PMC2887326</ArticleId><ArticleId IdType="pubmed">18955318</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayama S, Kikuchi A, Makino T, Kainuma M, Namiki T, Ito T. Basic pharmacological mechanisms and clinical evidence of the efficacy of Hochuekkito against infectious diseases and its potential for use against COVID-19. Traditional &amp; Kampo Medicine. 2021;8(1):3&#x2013;21. doi: 10.1002/tkm2.1264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tkm2.1264</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T. Kampo therapy for ME/CFS in Japan. Clin J Trad Chin Med. 2021;42(4):468&#x2013;473.</Citation></Reference><Reference><Citation>Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr Cancer Ther. 2010;9(4):331&#x2013;338. doi: 10.1177/1534735410383170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1534735410383170</ArticleId><ArticleId IdType="pubmed">21059621</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T, Komiyama H, Nakagawa T. MAtsuura T, Oka K: Studies on the effects of rikkunshi-to and hochuekki-to on adrenal and autonomic nervous functions. Jpn J Oriental Med. 1993;43(3):439&#x2013;446.</Citation></Reference><Reference><Citation>He Q, Sawada M, Yamasaki N, Akazawa S, Furuta H, Uenishi H, Meng X, Nakahashi T, Ishigaki Y, Moriya J. Neuroinflammation, oxidative stress, and neurogenesis in a mouse model of chronic fatigue syndrome, and the treatment with kampo medicine. Biol Pharm Bull. 2020;43(1):110&#x2013;115. doi: 10.1248/bpb.b19-00616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b19-00616</ArticleId><ArticleId IdType="pubmed">31902915</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>